| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |